As of Feb 23
| +0.0809 / +8.35%|
The 1 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +1,042.86% increase from the last price of 1.05.
The current consensus among 1 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.